1. Home
  2. GPCR vs JBI Comparison

GPCR vs JBI Comparison

Compare GPCR & JBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • JBI
  • Stock Information
  • Founded
  • GPCR 2016
  • JBI 2002
  • Country
  • GPCR United States
  • JBI United States
  • Employees
  • GPCR N/A
  • JBI N/A
  • Industry
  • GPCR
  • JBI Building Products
  • Sector
  • GPCR
  • JBI Industrials
  • Exchange
  • GPCR Nasdaq
  • JBI Nasdaq
  • Market Cap
  • GPCR 1.1B
  • JBI 924.6M
  • IPO Year
  • GPCR 2023
  • JBI N/A
  • Fundamental
  • Price
  • GPCR $21.76
  • JBI $8.16
  • Analyst Decision
  • GPCR Strong Buy
  • JBI Buy
  • Analyst Count
  • GPCR 8
  • JBI 6
  • Target Price
  • GPCR $79.29
  • JBI $9.80
  • AVG Volume (30 Days)
  • GPCR 755.1K
  • JBI 1.4M
  • Earning Date
  • GPCR 05-08-2025
  • JBI 05-08-2025
  • Dividend Yield
  • GPCR N/A
  • JBI N/A
  • EPS Growth
  • GPCR N/A
  • JBI N/A
  • EPS
  • GPCR N/A
  • JBI 0.35
  • Revenue
  • GPCR N/A
  • JBI $919,800,000.00
  • Revenue This Year
  • GPCR N/A
  • JBI N/A
  • Revenue Next Year
  • GPCR N/A
  • JBI $6.00
  • P/E Ratio
  • GPCR N/A
  • JBI $23.07
  • Revenue Growth
  • GPCR N/A
  • JBI N/A
  • 52 Week Low
  • GPCR $13.22
  • JBI $5.99
  • 52 Week High
  • GPCR $62.74
  • JBI $15.24
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 39.75
  • JBI 55.38
  • Support Level
  • GPCR $22.09
  • JBI $8.01
  • Resistance Level
  • GPCR $24.98
  • JBI $8.42
  • Average True Range (ATR)
  • GPCR 1.64
  • JBI 0.26
  • MACD
  • GPCR -0.54
  • JBI -0.05
  • Stochastic Oscillator
  • GPCR 4.64
  • JBI 15.82

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About JBI Janus International Group Inc.

Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.

Share on Social Networks: